These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28767207)

  • 1. Paliperidone-Induced Hyponatremia.
    Tibrewal P; Dhillon R; Sharma J; Bastiampillai T
    Prim Care Companion CNS Disord; 2017 Jul; 19(4):. PubMed ID: 28767207
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral Facial Dystonia (Meige or Brueghel Syndrome) Induced by Paliperidone Palmitate.
    Marques JG
    Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28129491
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.
    Legrand G; Andrianarisoa M; Mauvieux J; Jalenques I
    J Clin Psychopharmacol; 2014 Oct; 34(5):652-3. PubMed ID: 25006816
    [No Abstract]   [Full Text] [Related]  

  • 4. A patient with multiple episodes of rhabdomyolysis induced by different neuroleptics.
    Aggarwal R; Guanci N; Marambage K; Caplan JP
    Psychosomatics; 2014; 55(4):404-408. PubMed ID: 24016383
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of clinical observation: A case of subtle tardive dyskinesia with paliperidone palmitate.
    Omer HM; Thompson AD
    Aust N Z J Psychiatry; 2018 May; 52(5):496-497. PubMed ID: 29338294
    [No Abstract]   [Full Text] [Related]  

  • 6. Paliperidone Palmitate-Associated Severe Refractory Tardive Dyskinesia With Tardive Dystonia: Management and Six-Months Follow-Up.
    Singh S; Gupta A; Kuppili PP; Pattanayak RD; Khandelwal SK
    J Clin Psychopharmacol; 2016 Aug; 36(4):391-3. PubMed ID: 27269958
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Paliperidone Palmitate Throughout a Schizoaffective Disorder Patient's Gestation Period.
    Zamora Rodríguez FJ; Benítez Vega C; Sánchez-Waisen Hernández MR; Guisado Macías JA; Vaz Leal FJ
    Pharmacopsychiatry; 2017 Jan; 50(1):38-40. PubMed ID: 27414740
    [No Abstract]   [Full Text] [Related]  

  • 8. Paliperidone-Associated Hyponatremia: Report of a Fatal Case With Analysis of Cases Reported in the Literature and to the US Food and Drug Administration Adverse Event Reporting System.
    Mazhar F; Carnovale C; Haider N; Ahmed R; Taha M
    J Clin Psychopharmacol; 2020; 40(2):202-205. PubMed ID: 32068565
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimated medical cost reductions for paliperidone palmitate vs placebo in a randomized, double-blind relapse-prevention trial of patients with schizoaffective disorder.
    Joshi K; Lin J; Lingohr-Smith M; Fu DJ
    J Med Econ; 2015; 18(8):629-36. PubMed ID: 25800457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paliperidone-Associated Atrioventricular Block.
    Yasin M; Lateef N; Pervaiz MH
    Am J Ther; 2018; 25(6):e730-e732. PubMed ID: 29528883
    [No Abstract]   [Full Text] [Related]  

  • 11. Lithium carbonate as a treatment for paliperidone extended-release-induced leukopenia and neutropenia in a patient with schizoaffective disorder; a case report.
    Matsuura H; Kimoto S; Harada I; Naemura S; Yamamuro K; Kishimoto T
    BMC Psychiatry; 2016 May; 16():161. PubMed ID: 27229149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation.
    Mauri MC; Reggiori A; Paletta S; Di Pace C; Altamura AC
    Expert Opin Drug Saf; 2017 Mar; 16(3):365-379. PubMed ID: 28140680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute agranulocytosis when switching from risperidone to paliperidone.
    Wakuda T; Suzuki A; Hasegawa M; Ichikawa D; Yamasue H
    Aust N Z J Psychiatry; 2019 Jun; 53(6):586-587. PubMed ID: 30636434
    [No Abstract]   [Full Text] [Related]  

  • 14. Paliperidone Injection-Associated Delayed-Onset Rash.
    Sundling K; Held J; Narang P; Lippmann S
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30817863
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs for psychotic disorders.
    Med Lett Drugs Ther; 2016 Dec; 58(1510):160-164. PubMed ID: 27960194
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute psychosis in a polyglot: Linguistic regression to the mother tongue and restoration.
    Saito S
    Asian J Psychiatr; 2019 Jun; 43():91-92. PubMed ID: 31112897
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of severe hypothermia following three-month administration of paliperidone palmitate: a case report.
    Fernández-Bargiela N; Yáñez-Rubal JC; Vázquez-Ventoso C; Cid-Silva P; Martín-Herranz I
    Actas Esp Psiquiatr; 2020 Jul; 48(4):181-90. PubMed ID: 32920784
    [No Abstract]   [Full Text] [Related]  

  • 18. Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.
    Jarema M; Bieńkowski P; Heitzman J; Parnowski T; Rybakowski J
    Psychiatr Pol; 2017 Feb; 51(1):7-21. PubMed ID: 28455891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attributing hyponatraemia to treatment with antipsychotic medications.
    Josiassen RC; Shaughnessy RA; Filmyer DM; Audino B
    Drug Saf; 2011 Apr; 34(4):353-4; author reply 354-5. PubMed ID: 21417508
    [No Abstract]   [Full Text] [Related]  

  • 20. Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management.
    Muthu MS; Sahu AK; Sonali ; Abdulla A; Kaklotar D; Rajesh CV; Singh S; Pandey BL
    Drug Deliv; 2016; 23(1):230-7. PubMed ID: 24853962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.